Clinical Trials in Nashville

Showing 6681-6700 of 20,298 trials

Long Term Follow Up Protocol for NiCord®/CordIn™ (Omidubicel) Patients

NCT02039557

This is an observational study that will monitor clinical outcomes of patients who have received a NiCord®/CordIn™ (omidubicel) transplant as part of a GC clinical interventional study and meet the eligibility criteria for this Long Term Follow Up study.

Patients Transplanted With NiCord/CordIn (Omidubicel)

Gamida Cell ltd33 participantsStarted May 2014

Oakland, California, United States • Maywood, Illinois, United States • Durham, North Carolina, United States +7 more locations

COMPLETEDPhase 2< 1 mile

High Dose Flu Vaccine in Treating Children Who Have Undergone Donor Stem Cell Transplant

NCT02860039

This phase II randomized trial studies how well high dose flu vaccine works in treating children who have undergone done stem cell transplant. Higher dose flu vaccine may build a better immune response and may provide better protection against the flu than the standard vaccine.

Hematopoietic Cell Transplantation RecipientMalignant NeoplasmInfluenza

Vanderbilt-Ingram Cancer Center170 participantsStarted Sep 2016

San Francisco, California, United States • Kansas City, Missouri, United States • Cincinnati, Ohio, United States +6 more locations

Long Term Follow Up Protocol for NiCord®/CordIn™ (Omidubicel) Patients

High Dose Flu Vaccine in Treating Children Who Have Undergone Donor Stem Cell Transplant

Find Trials by Condition in Nashville

TriVerity in the Diagnosis and Prognosis of Emergency Department Patients With Suspected Infections and Suspected Sepsis

Vitamin D to Improve Outcomes by Leveraging Early Treatment: Long-term Brain Outcomes in Vitamin D Deficient Patients

Cytomegalovirus (CMV) Vaccine in Donors and Recipients Undergoing Allogeneic Hematopoietic Cell Transplant (HCT)

Bentracimab in Ticagrelor-treated Patients With Uncontrolled Bleeding or Requiring Urgent Surgery or Invasive Procedure

A Study to Evaluate the Safety of Long-term Ivacaftor Treatment in Participants With Cystic Fibrosis Who Are Less Than 24 Months of Age at Treatment Initiation and Have an Approved Ivacaftor-Responsive Mutation

Assess Aesthetic Improvement and Onset of QM1114-DP in Subjects With Moderate to Severe Glabellar Lines

Safety and Efficacy of Vancomycin Ophthalmic Ointment in Patients With Moderate to Severe Bacterial Conjunctivitis

Assessment of Macrophage Activation syndromE in STill's Disease

Pediatric Arthritis Study of Certolizumab Pegol

Long-term Efficacy and Safety of OLE LIB003 in HoFH, HeFH, and High-risk CVD Patients Requiring Further LDL-C Reduction

A Study for Participants With Spinal Muscular Atrophy (SMA) Who Previously Participated in Nusinersen (ISIS 396443) Investigational Studies

First in Human Study of TORL-2-307-MAB in Participants With Advanced Cancer

Stockholm3 Validation Study in a Multi-Ethnic Cohort

Study of the Safety, Pharmacokinetics and Efficacy of Tinostamustine in Patients With Advanced Solid Tumors.

A Study of NT 201 Doses in the Treatment of Platysma Prominence

Study to Compare the Use of a Behavioral Health App Versus Care As Usual for 16-22 Year Olds with Depression

A Study of Atezolizumab Compared With a Single-Agent Chemotherapy in Treatment Naïve Participants With Locally Advanced or Recurrent or Metastatic Non-Small Cell Lung Cancer Who Are Deemed Unsuitable For Platinum-Doublet Chemotherapy

A Study to Learn About the Effects of Sisunatovir in Infants With Respiratory Syncytial Virus Lower Respiratory Tract Infection.